Key Sessions
keyboard_arrow_right
Search & Filter keyboard_arrow_right
keyboard_arrow_left Hide
Conference Day One
keyboard_arrow_leftSearch & Filter
search
Streams
Conference Day One
search
Streams
8:00am - 9:00am60 mins
Registration and Coffee
9:00am - 9:15am15 mins
Workshop #2: Current Topics in Peptide Discovery and Development: A Focus on Improving Peptide Properties
Workshop Moderator’s Opening Remarks
- Bruce Morimoto, PhD - Vice President, Drug Development, Cerecin
9:00am - 10:30am90 mins
Workshop #1: Path to a Successful IND/IMPD for Oligonucleotide Therapeutics
Part 1: Nonclinical Perspective
- Jennifer Lockridge, PhD - Senior Vice President, Program Development, Dicerna Pharmaceuticals, Inc.
9:15am - 9:45am30 mins
Workshop #2: Current Topics in Peptide Discovery and Development: A Focus on Improving Peptide Properties
An Overview of Peptide Drug Development and Factors for Success
- Bruce Morimoto, PhD - Vice President, Drug Development, Cerecin
9:45am - 10:45am60 mins
Workshop #2: Current Topics in Peptide Discovery and Development: A Focus on Improving Peptide Properties
Introduction to General Side Reactions in Peptide Synthesis and Prediction of Peptide Drug Chemical Stability
- Yi Yang, Ph.D. - Senior Research Scientist, Chemical Development &, Ferring Pharmaceuticals A/S
10:30am - 10:45am15 mins
Workshop #1: Path to a Successful IND/IMPD for Oligonucleotide Therapeutics
Q&A for Part 1
- Jennifer Lockridge, PhD - Senior Vice President, Program Development, Dicerna Pharmaceuticals, Inc.
10:45am - 11:15am30 mins
Networking Refreshment Break
11:15am - 12:30pm75 mins
Workshop #1: Path to a Successful IND/IMPD for Oligonucleotide Therapeutics
Part 2: CMC Perspective
- G. Susan Srivatsa, PhD - President, ElixinPharma
11:15am - 12:00pm45 mins
Workshop #2: Current Topics in Peptide Discovery and Development: A Focus on Improving Peptide Properties
Prolonging Peptide Half-Life with Modifications (PEG, Lipid) and Implications for Manufacturing
- Robert Hagopian - Director Business Development, PolyPeptide Group
12:00pm - 12:45pm45 mins
Workshop #2: Current Topics in Peptide Discovery and Development: A Focus on Improving Peptide Properties
An Overview of Peptides and Immunogenicity
- Brian Roberts, PhD - Associate Scientific Director of Protein Therapeut, Epivax
12:30pm - 12:45pm15 mins
Workshop #1: Path to a Successful IND/IMPD for Oligonucleotide Therapeutics
Q&A for Part 2
- G. Susan Srivatsa, PhD - President, ElixinPharma
12:45pm - 12:50pm5 mins
Close of Workshops
2:00pm - 2:05pm5 mins
Main Conference Plenary Keynote Session
Chairperson’s Remarks
2:05pm - 2:40pm35 mins
Main Conference Plenary Keynote Session
Crossing the Barriers and Boundaries I: Delivery of RNAi Therapeutics
- Muthiah (Mano) Manoharan, PhD - Senior Vice President of Drug Discovery, Alnylam Pharmaceuticals, Inc.
2:40pm - 3:15pm35 mins
Main Conference Plenary Keynote Session
Crossing the Barriers and Boundaries II: Towards Global Approval for Onpattro and other RNAi Therapeutics
- Barry Greene - President, Alnylam Pharmaceuticals
3:15pm - 3:50pm35 mins
Networking Refreshment Break
3:50pm - 4:25pm35 mins
Main Conference Plenary Keynote Session
Various Therapeutic Applications from PeptiDream: Recent Advancements of Peptide-drug Conjugates
- Keiichi Masuya, PhD - Executive Vice President, PeptiDream, Inc.
4:25pm - 5:00pm35 mins
Main Conference Plenary Keynote Session
New Stage of DNA/RNA Heteroduplex Oligonucleotide
- Takanori Yokota, MD, PhD - Professor, Neurology and Neurological Science, Tokyo Medical and Dental University
5:00pm - 6:00pm60 mins
Close of Day One
Get the latest news.
As it happens
Sign up to get the latest on the agenda and speakers.
Filter
Streams